Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Change in Account Payables (2018 - 2025)

Historic Change in Account Payables for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$175000.0.

  • Dna X's Change in Account Payables fell 6203.7% to -$175000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year increase of 49253.11%. This contributed to the annual value of $14.3 million for FY2024, which is 121876.47% up from last year.
  • Dna X's Change in Account Payables amounted to -$175000.0 in Q3 2025, which was down 6203.7% from $3.3 million recorded in Q2 2025.
  • Dna X's Change in Account Payables' 5-year high stood at $13.8 million during Q4 2024, with a 5-year trough of -$5.6 million in Q1 2025.
  • Over the past 5 years, Dna X's median Change in Account Payables value was $311000.0 (recorded in 2023), while the average stood at $1.2 million.
  • Over the last 5 years, Dna X's Change in Account Payables had its largest YoY gain of 376941.18% in 2025, and its largest YoY loss of 112851.85% in 2025.
  • Quarter analysis of 5 years shows Dna X's Change in Account Payables stood at -$3.0 million in 2021, then surged by 386.74% to $8.7 million in 2022, then crashed by 139.22% to -$3.4 million in 2023, then skyrocketed by 504.58% to $13.8 million in 2024, then tumbled by 101.27% to -$175000.0 in 2025.
  • Its Change in Account Payables was -$175000.0 in Q3 2025, compared to $3.3 million in Q2 2025 and -$5.6 million in Q1 2025.